AI Driven De Novo Design with REINVENT

webinar

Thu, 24 Jun 2021, 16:00 CEST (Berlin)

Dr. Atanas Patronov, Astrazeneca

AI Driven De Novo Design with REINVENT

The goal of de novo design is to identify novel active compounds that can simultaneously satisfy a combination of essential optimization goals such as activity, selectivity, physical-chemical and ADMET properties. It is a process of generating novel compounds from scratch that are normally not present in databases and are not being previously considered in the context of the given target. Identifying a compound that meets all these criteria is still far from trivial.

In this talk we will discuss how AI has been adopted for the needs of de novo design of small molecules. We will illustrate this in the context of REINVENT, which is a platform developed internally within AstraZeneca and made open source. It is based on using different flavors of generative models that know how to generate small molecules. The generative models are be placed in various learning scenarios and can learn to generate molecules that satisfy a diverse set of criteria thus elegantly serving the needs of de novo design.

Current news

25 Years of BioSolveIT: Thank You!
November 20, 2026 06:37 CET
Your targets. Your compounds. Your questions. For our 25th anniversary, we opened up free access to SeeSAR and Chemical Space DockingĀ® through November 15. The idea was simple: give you time to see what the tools could do with a target or compound you already knew well. Maybe you revisited...
Read on
CHEMriya Update November
November 11, 2026 11:19 CET
More Chemistry. More Possibilities. The latest update of CHEMriya brings over 794 billion virtual product molecules to your compound exploration. Developed by OTAVA in collaboration with BioSolveIT, this on-demand Chemical Space opens up new opportunities for hit expansion, hit-to-lead optimization, and compound evolution. The November 2026 release combines OTAVA’s chemistry...
Read on
category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on